Vivus (Nasdaq: VVUS) is recently up 7c to $11.02. A U.S. FDA advisory committee is tentatively set to review ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE